Assessing the reporting quality of randomized controlled trials on COVID-19 vaccines: a systematic reviewCOVID-19 백신에 대한 무작위 대조 시험의 보고 품질 평가: 체계적인 검토Article Published on 2022-12-312022-09-11 Journal: Human vaccines & immunotherapeutics [Category] 임상, [키워드] adverse effect Analysis analysis of variance Assessing CONSORT CONSORT statement controlled trials COVID-19 COVID-19 vaccine COVID-19 vaccines criteria current database effective evaluated Evidence groups independent indicate indicated median Mortality no significant difference predicted Randomized Randomized controlled trial Randomized controlled trials RCT RCTs reported Reporting Reporting quality review. Standard systematic review Univariate analysis variance variety [DOI] 10.1080/21645515.2022.2031453 PMC 바로가기 [Article Type] Article
Safety and immunogenicity of the first Kazakh inactivated vaccine for COVID-19Article Published on 2022-11-302022-11-15 Journal: Human vaccines & immunotherapeutics [Category] SARS, 진단, [키워드] adverse effect animal models antibody Antibody titer BALB/c mice changes in class COVID-19 COVID-19 vaccine demonstrated did not produce ELISA ENhance enzyme-linked immunosorbent ferrets Gender general condition GMT group growth hamster hamsters Health histology immune response immunization immunogenicity Inactivated vaccine injection internal organ Kazakhstan lowest microneutralization MNA nontoxic preclinical trials rhesus macaque Safety significant difference statistically significant Toxicity Vaccine vaccine. were assessed [DOI] 10.1080/21645515.2022.2087412 PMC 바로가기
Post-vaccination COVID Toes (Chilblains) Exacerbated by Rituximab Infusion Suggests Interferon Activation as MechanismArticle Published on 2022-10-292022-11-15 Journal: Military Medicine [Category] 진단, [키워드] Activation acute respiratory syndrome adverse effect chilblains coronavirus COVID disease infusion interferon mechanism Pfizer presenting rituximab significantly skin lesion Toe Vaccine worsened [DOI] 10.1093/milmed/usab314 PMC 바로가기
Artificial Cell Membrane Polymersome-Based Intranasal Beta Spike Formulation as a Second Generation Covid-19 VaccineArticle Published on 2022-10-252022-11-15 Journal: ACS Nano [Category] COVID19(2023년), SARS, 변종, 비임상, 진단, [키워드] ACM acute respiratory syndrome adverse effect airway antibodies antibody antigen presenting cells artificial Beta Beta spike C57BL/6 cell membrane clinical symptom clinical trial component conditions coronavirus coronavirus disease COVID-19 CpG cross-neutralizing current delivery of cargo dendritic cells dose doses evaluate evaluated Formulation generate Generation Good hamster hamsters immune responses immunization immunogenic induce Infection initiated interval intranasal mice neutralize neutralizing antibody neutralizing responses New omicron Phase 1 polymersome Practice PROTECT reduction repeated Safety SARS-CoV-2 second serum IgG spike Spike protein Spike-based vaccine Support Toxicity upper respiratory tract Vaccine vaccine. variants viral clearance Viral load virus weight loss wild type [DOI] 10.1021/acsnano.2c06350 PMC 바로가기
Case Report: A 29-Year-Old Pregnant Woman at 24 Weeks of Gestation Presenting with Laryngotracheitis and COVID-19 Due to the R.1 Variant of SARS-CoV-2Article Published on 2022-10-182022-11-16 Journal: The American journal of case reports [Category] COVID19(2023년), SARS, 변종, [키워드] acute respiratory syndrome Admission Adults adverse effect causes coronavirus Corticosteroid Corticosteroids cough COVID-19 discharge discharged disease E484K mutation edema Fever gestation healthy hospital Hospitalized Inhaled laryngotracheitis Lower respiratory tract nebulized oxygen saturation PCR polymerase chain positive Pregnancy Pregnant woman pregnant women presenting primary care SARS-CoV-2 severe disease course sore throat Symptom Symptoms treated Treatment variant of SARS-CoV-2 Week with COVID-19 woman Wuhan, China [DOI] 10.12659/AJCR.937834 PMC 바로가기
Safety and immunogenicity of intradermal administration of fractional dose CoronaVac®, ChAdOx1 nCoV-19 and BNT162b2 as primary series vaccinationArticle Published on 2022-10-042022-11-15 Journal: Frontiers in Immunology [Category] COVID19(2023년), SARS, 변종, 진단, 치료기술, [키워드] administration Adverse adverse effect anti-RBD Anti-RBD IgG antibody Antibody Response Arm ARMS binding domain BNT162b2 ChAdOx1 ChAdOx1 nCoV-19 comparable Concentration conducted CoronaVac country COVID COVID vaccine COVID-19 COVID-19 vaccine COVID-19 vaccines dose Effect Effects eligible exploratory first dose fractional dose vaccination Frame Heterologous heterologous regimen highest homologous IgG immunogenic implication IMPROVE Intradermal intradermal vaccination intradermal vaccine intramuscular intramuscular vaccination less lowest of BNT162b2 Omicron variant pilot study Population Protein regimen regimens reported Safe Safety SARS-CoV-2 variants second dose spike Standard dose Study participants systemic adverse reaction T-cell Response the SARS-CoV-2 undetectable vaccination Vaccine vaccine immunogenicity vaccine safety. [DOI] 10.3389/fimmu.2022.1010835 PMC 바로가기
Management of Cerebral Venous Thrombosis Due to Adenoviral COVID-19 VaccinationArticle Published on 2022-10-012022-11-15 Journal: Annals of neurology [Category] COVID19(2023년), SARS, 진단, [키워드] 95% CI 95% confidence interval adenovirus-based adjusted adjusted odds ratio administration adverse effect analyzed ANN Anticoagulant Anticoagulants association autoimmune pathogenesis avoidance caused cerebral country COVID-19 diagnosed evaluate had no heparin hospital immune immunomodulation International Intravenous immunoglobulin lower mortality Mortality Patient Platelet recommendation reducing mortality SARS-CoV-2 SARS-CoV-2 vaccination significantly statistically significant the patient thrombotic treated Treatment used data Vaccines Venous thrombosis [DOI] 10.1002/ana.26431 PMC 바로가기
Interactions of the protease inhibitor, ritonavir, with common anesthesia drugsArticle Published on 2022-10-012022-11-15 Journal: Paediatric anaesthesia [Category] 치료제, [키워드] administration adverse effect affected Altered Anesthesia Antiviral antiviral drug approach Bioavailability change changes in children clearance Combination Comorbidities Concentration COVID-19 dependent on drug drug clearance drug dose Drug interactions early treatment enzyme example fentanyl increase in inhibited inhibitor inhibitory intrinsic management metabolic pathways pathway Patient pharmacodynamics. pharmacokinetic plasma concentration propofol Protease inhibitor remifentanil responsible Ritonavir subject Variability [DOI] 10.1111/pan.14529 PMC 바로가기
Constrictive pericarditis following inactivated virus COVID-19 vaccine: a case report with review of the literatureCase report Published on 2022-10-012022-10-05 Journal: Radiology Case Reports [Category] 진단, [키워드] accelerate adverse effect BBIBP-CorV (Vero Cells) cardiac Case report catheterization chest CT scan Constrictive pericarditis corticosteroid therapy Course COVID-19 COVID-19 vaccine Diagnosis diagnostic diagnostic investigation diagnostic test dose etiology exclusion favor heart failure immunization inactivated Inactivated vaccine Inflammation invasive lack male mRNA COVID-19 vaccines myocarditis Patient physician provoke receiving reported SARS-CoV-2 Symptom the patient virus was performed [DOI] 10.1016/j.radcr.2022.07.021 [Article Type] Case report
Impact of COVID-19 on male urogenital health: Success of vaccinesReview article Published on 2022-10-012022-10-05 Journal: Drug discovery today [Category] COVID19(2023년), SARS, 신약개발, 임상, [키워드] acute respiratory syndrome adverse effect angiotensin-converting enzyme 2 approval Community consequence coronavirus COVID-19 COVID-19 pandemic COVID-19 vaccinations Erectile dysfunction Impact information male management morbidity and mortality Prostate SARS-CoV-2 treatment protocols Urinary bladder Vaccine [DOI] 10.1016/j.drudis.2022.07.012 [Article Type] Review article